<code id='89FEA8326A'></code><style id='89FEA8326A'></style>
    • <acronym id='89FEA8326A'></acronym>
      <center id='89FEA8326A'><center id='89FEA8326A'><tfoot id='89FEA8326A'></tfoot></center><abbr id='89FEA8326A'><dir id='89FEA8326A'><tfoot id='89FEA8326A'></tfoot><noframes id='89FEA8326A'>

    • <optgroup id='89FEA8326A'><strike id='89FEA8326A'><sup id='89FEA8326A'></sup></strike><code id='89FEA8326A'></code></optgroup>
        1. <b id='89FEA8326A'><label id='89FEA8326A'><select id='89FEA8326A'><dt id='89FEA8326A'><span id='89FEA8326A'></span></dt></select></label></b><u id='89FEA8326A'></u>
          <i id='89FEA8326A'><strike id='89FEA8326A'><tt id='89FEA8326A'><pre id='89FEA8326A'></pre></tt></strike></i>

          hotspot

          hotspot

          author:explore    Page View:61823

          How do cancer drugs work? What makes biotech stocks go up? And why are venture capitalists so optimistic?

          We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Andrew Joseph joins us to explain the decades-old cancer-treating technology that had its star turn at this week’s big oncology conference in Europe. We also discuss the latest news in the life sciences, including the future of Alzheimer’s disease treatment, a multibillion-dollar deal, and the return of the biotech mega-round.

          advertisement

          For more on what we cover, here’s STAT’s coverage of the European Society for Medical Oncology meeting; here’s more on Roivant Sciences; here’s the latest on biotech venture capital; here’s more on the latest Alzheimer’s data; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

          advertisement

          explore

          State Dept. review finds Biden bears some blame for Afghanistan failures
          State Dept. review finds Biden bears some blame for Afghanistan failures

          3:53HundredsofpeoplegathernearaU.S.AirForceC-17transportplaneattheperimeteroftheinternationalairport

          read more
          Akero's treatment for NASH falls short in cirrhosis study
          Akero's treatment for NASH falls short in cirrhosis study

          AdobeAkeroTherapeuticssaidTuesdaythatanexperimentalmedicinefailedtoshowasignificantbenefitforpatient

          read more
          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more

          Aspartame and sugar

          AdobeTheInternationalAgencyforResearchonCancer(IARC,anentitywithintheWorldHealthOrganization)recentl